We examined the effects of 48h of knee immobilization on alterations in mRNA and protein in human skeletal muscle. We hypothesized that 48h of immobilization would increase gene expression and respective protein products for ubiquitin proteasome pathway (UPP) components. Also, we used microarray analysis to identify novel pathways. Biopsies were taken from the vastus muscle of five men (20.4 + 0.5 years) before and after 48h immobilization. Global changes in gene expression were analyzed using Affymetrix GeneChips. Candidate genes were confirmed via quantitative real time polymerase chain reaction (qRT-PCR). Western blotting (WB) was used to quantify protein products of candidate genes and to assess Akt pathway activation.
INTRODUCTION
Skeletal muscle adapts rapidly to changes in activity (12) . In fact, humans who have had a limb immobilized due to injury or illness experience significant losses in muscle mass and function within one to two weeks (20, 36) . Although studies in humans have documented the effects of immobilization on skeletal muscle structure and function (5, 6, 25, 36) , the underlying mechanism regulating rapid muscle protein degradation remains uncertain. Investigations of limb immobilization in animals have shown that there is a coordinated upregulation of genes encoding for proteins that function in the initiation of the muscle atrophy process (8, 14, 42, 51) .
The majority of genes upregulated by muscle atrophy in animal models can be classified into the ubiquitin proteasome pathway. This pathway is the intracellular proteolytic pathway responsible for the bulk of protein degradation in skeletal muscle, and it is induced in animal models by unloading, spaceflight, immobilization, denervation, or wasting (7, 8, 19, 22, 33, 37, 48, 51) . Ubiquitin-mediated proteolysis is ATP-dependent and relies on the selectivity of ubiquitin-conjugating enzymes (E2's) and ubiquitinprotein ligases (E3's) to tag and degrade specific proteins within the cell. An increase in proteolytic activity is initiated by an increase in mRNAs encoding essential components of the ubiquitin proteasome pathway, and this increase is followed by a respective increase in protein products (24, 30, 34, 38, 44, 54 ).
Bodine et al. (8) analyzed mRNA expression after immobilization of the rat gastrocnemius muscle. The mRNA content of two genes that encode E3 ubiquitin ligases, Muscle RING Finger 1 (MuRF1) and Muscle Atrophy F-box (MAFbx/Atrogin-1) were upregulated two days following immobilization. Multiple immobilization interventions in animals have reproduced these results (8, 30, 51) , while gene responses of factors in this pathway in human skeletal muscle in response to similar perturbations remains elusive. In an investigation of gene expression profiles at various time points during hindlimb immobilization in rats, Stevenson and colleagues (51) reported an upregulation of mRNA for genes that encode proteasome subunits, as well as the ubiquitin ligases 24h following immobilization, and this upregulation was not diminished following 14 days of immobilization. Similarly, a microarray analysis of rat muscle undergoing atrophy from various causes (e.g. sepsis, uremia, wasting) showed that genes encoding the E3 ubiquitin ligases (MuRF1 and MAFbx), polyubiquitins and cathepsin-L were upregulated during atrophy (32) . Others reported that mRNA for E2 conjugating-enzymes and E3 ligases are upregulated greater than 2-fold within two days of hindlimb suspension, denervation, or immobilization (14, 18, 42) . Collectively, the muscle atrophy work performed in animals demonstrates similar trends in the expression of genes involved in the ubiquitin proteasome pathway, suggesting that muscle atrophy in animals is secondary to increased protein breakdown via an upregulation of the ATP-ubiquitin-dependent proteolytic pathway (22, 23) .
Signaling mechanisms that activate the ubiquitin proteasome pathway and the subsequent loss of muscle tissue are not well defined. Much research has focused on the role of insulin and Insulin-like growth factor (IGF-I) signaling pathways in animal models because of the predominant role insulin and IGF-I play in reducing protein degradation (47) . Moreover, previous work has shown that insulin resistance is evident in catabolic conditions that are associated with activation of the ubiquitin proteasome pathway, and treatment with IGF-I is sufficient to attenuate activity of this pathway (9, 15, 19) . Recent work in animals has focused on the role of the phosphatidylinositol-3-kinase (PI3K)/Akt (Protein Kinase B) signaling pathway as a central regulator between insulin and IGF-I receptor-binding and activation of proteolytic or synthesis machinery in skeletal muscle (9, 15, 21, 47) . There is strong evidence in animal models that the activity of the PI3K/Akt pathway is a regulator of the muscle atrophy program (9, 14, 30, 45) . However, this relationship in humans, particularly in response to disuse, is not known. Few researchers are confirming and extending results of animal models to humans and without this intermediate step, the translation into effective therapies is slowed down.
To date, we are aware of only one study in humans that has investigated the effects of an atrophy-related stimulus on alterations in gene expression in human skeletal muscle (24) .
Although this study is an important contribution to atrophy literature, the authors used a targeted approach to identify alterations in gene expression, preventing a comprehensive analysis of all genes affected by the immobilization intervention. Moreover, the analysis was performed after two weeks of immobilization, and early changes in gene expression responsible for the initiation of the atrophy program remain unknown. Finally, these alterations were only explored at the mRNA level, and alterations in protein products were not investigated.
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Therefore, we sought to identify alterations at the mRNA and protein level in human skeletal muscle after 48h of limb immobilization to identify early regulators of the muscle atrophy program in humans. Based on previous work in animals (8, 9, 30) , we hypothesized that analysis of human skeletal muscle biopsies taken after 48h of limb immobilization, would show an increase in gene expression and respective protein products for components of the ubiquitin proteasome pathway and alterations in the phosphorylation of proteins involved in the Akt signaling pathway associated with decreased protein synthesis. Furthermore, we used microarray analysis to identify novel pathways involved in the atrophy program activated in response to 48h of limb immobilization in humans. We chose to use a multi-faceted approach of microarray analysis, quantitative real-time polymerase chain reaction (qRT-PCR), immunoblotting, and immunohistochemistry (IHC) to identify critical regulators of the atrophy program at both the mRNA and protein level in humans after 48h of limb immobilization.
METHODS

Subjects
Five men completed the study. Mean (+SE) age, height and weight of the subjects were 20.4 + 0.5 yrs, 173.2 + 2.2 cm, and 77.7 + 1.5 kg, respectively. All participants provided signed consent as approved by the University of Massachusetts and Hartford Hospital Institutional Review Boards and completed a medical history questionnaire. Subjects were sedentary, but ambulatory; healthy, with no orthopedic problems that would be exacerbated by the immobilization intervention. Subjects who were taking muscle building supplements or restricting calorie intake were excluded from the study.
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Design
At baseline, subjects reported to the laboratory and were given a standardized meal since meal patterns alter the activity of certain genes that are downstream of AKT (15), a potent regulator of the muscle atrophy program. Approximately 2h later, a biopsy of the right vastus lateralis muscle was taken to use as a baseline control. Ten days following the pre-immobilization, baseline biopsy, subjects returned to the laboratory. At this time, the left leg was immobilized (knee angle = 160°) in a cylinder leg brace (Donjoy ® , Vista, CA) that extended from below the groin to the ankle. The brace was secured with fiberglass casting tape. Subjects were contacted twice daily to ensure compliance and that the immobilized leg was not causing undue discomfort. Forty-six hours postimmobilization subjects were given a standardized meal and approximately 2h later, a biopsy of the left vastus lateralis (the limb that was immobilized). This biopsy was scheduled for the same time of day as the pre-immobilization biopsy to reduce influence of circadian rhythms on changes in gene expression. We decided to take the pre-and post-immobilization muscle biopsies from opposite legs to avoid any contamination resulting from scar tissue at the earlier pre-immobilization biopsy site. In a previous study, we took muscle biopsies from opposite legs (53), and microarray analysis revealed that there were no differences in gene expression when samples were taken thirty days apart, establishing that levels of gene expression are not different between legs.
The brace was removed immediately prior to the biopsy while the subject was supine on the examination table. Once the biopsy was completed, subjects were given rehabilitation to ensure rapid recovery of knee range of motion.
Immobilization
Subjects had their left leg placed in a long cylinder leg brace (Donjoy ® ). The brace extended from below the groin to above the ankle joint. The brace was placed on the subject while the subject was standing. ) and subjects were able to bear weight on the leg. Subjects were able to ambulate normally during the immobilization. Therefore, casting of the knee joint prevented knee extension and prevented use of the vastus lateralis muscle.
Muscle Biopsy
Percutaneous needle muscle biopsies were obtained from the right (baseline) and left (48h post-immobilization) vastus lateralis muscles using a Bergstrom 5-mm biopsy needle (Depuy, Warsaw, IN). Skin was first lightly anesthetized with 4ml of 2% lidocaine hydrochloride solution, a small (5-6mm) incision was made in the skin and fascia, the biopsy needle was inserted, and ~200mg of tissue was removed. Tissue was divided into four, 50mg aliquots, snap frozen in liquid nitrogen, and stored at -80°C until analysis.
Gene Expression Profiling
Microarray analysis was performed using Affymetrix GeneChip ® (Affymetrix, Santa Clara, CA) technology (Human Genome U133 Plus 2.0 Array) with standard operating procedures and quality control as recently described (13 Statistical analysis was performed using a longitudinal design, where each subject served as their own control. This approach removes inter-individual variation due to genetic heterogeneity. Combined, these criteria increase the reliability of our microarray analysis allowing us to reduce false positives. Although multiple testing corrections were performed on our dataset, our small sample size resulted in all genes being eliminated from further analysis. Therefore, we took a systemic approach to confirm the microarray analysis using qRT-PCR, western blotting, and IHC. Also, candidate genes were selected only if they fulfilled three criteria: 1) they met the Affymetrix criteria described above for each subject (pre-vs. post-immobilization), 2) They showed a mean fold change > 1.5 or < -1.5, and 3) Welch's t-test detected a significant (p<0.05) increase or decrease in average fold-change for each subject in the pre-vs. post-immobilization comparison.
Genes that met all three criteria were then ranked according to p-value and fold-change, respectively. The top 25 up-and down-regulated genes were selected for confirmational analysis. Statistical analysis was performed on log transformed data to reduce inequalities of variance.
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
Total RNA was isolated and purified according to manufacturer's instructions using TRIZOL® reagent (Invitrogen) and measured on a Nanodrop ND-1000 for genes of interest (Table 1) .
qRT-PCR reactions were run in triplicate, in 96-well plates. On each plate, cDNA samples from pre-immobilization (control), and post-immobilization (48h) were run in triplicate for each gene of interest and for GAPDH which served as a reference standard.
The average Ct (threshold cycle) value for triplicate samples was used for data analysis. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Integrated DNA Technologies) was used to normalize the expression level of genes of interest. GAPDH is a constitutively expressed housekeeping gene and was not found to be differentially expressed in our microarray dataset. Relative quantitation of amplified mRNA was normalized to GAPDH, compensating for variations in quantity.
Western Blotting
Muscle samples (~50mg) used for Western blot analysis were homogenized in buffer 
Immunohistochemistry (IHC)
Serial cross-sectional slices (10µm) of muscle biopsy samples immersed in O.C.T.
embedding medium (Fisher Scientific, Pittsburgh, PA) were generated on a MICROM HM 505E Cryostat at -25ºC (Richard Allan Scientific, Kalamazoo, MI) and placed on glass slides coated with Vectabound reagent (Vector Laboratories, Burlingame, CA). All baseline and 48h samples were processed at the same time. Sections were washed in phosphate-buffered serum (PBS), pH 7.4 (Sigma), blocked with goat normal serum (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) or rabbit normal serum (Zymed Laboratories, San Francisco, CA) and stained overnight at 4ºC with primary antibodies used for Western blotting, diluted 1:250-1:500 in 5% BSA (Sigma) in PBS.
Sections were washed in PBS and were incubated for 30 min at 37ºC with secondary fluorochrome-labeled antibodies against primary antibodies (Alexa-green, Alexa-red, Goat Anti-mouse; Goat Anti-Rabbit, Rabbit Anti-Goat) (Molecular Probes, Eugene, OR).
Fluorochrome-labeled secondary antibodies, without primary antibodies, were used as controls. After washing with PBS, ~10µl of 3,3'-diaminobenzidine (Sigma) and a cover slip was added to each section.
Samples were visualized and photographed using a Nikon Eclipse E600 Phase Contrast Microscope (Nikon Corporation, Tokyo, Japan) equipped with a Spot insight QE camera and EclipseNET software, version 1.16. Scion IMAGE for Windows (Scion Corporation, Frederick, MD) was used for image analysis. Quantification of antibody staining was performed with the image analysis system in addition to manual microscopic scoring.
Exposure time and brightness were kept constant during image analysis.
Statistical Analysis
Values for qRT-PCR, Western blotting and IHC are given as means ± SE. Statistical comparisons were done using a paired Student's t-test, with p<0.05 indicating significance and p<0.10 indicating a trend.
RESULTS
Microarray analysis
Forty-eight hours of limb immobilization resulted in the differential expression of 737 transcripts according to inclusion criteria (p<0.05, fold change >1.5). Of these, 242 had known biological functions according to the Affymetrix NetAffyx Gene Ontology (GO) database (http://www.NetAffx.com). Overall, 120 were down regulated, and 122 were upregulated. Figure 1 presents a schematic of gene categories that were differentially expressed according to these criteria. In agreement with our hypothesis, among the top 25 upregulated genes were genes associated with the ubiquitin proteasome pathway.
Additionally, several genes involved in metallothionein function and the extracellular matrix were among the top 25 up-and down-regulated genes, respectively. This analysis provided a snapshot of the molecular changes that occur in response to 48h of immobilization. We therefore chose to perform additional work at the mRNA (qRT-PCR) and protein (Western blotting and IHC) level on a subset of genes involved in the ubiquitin proteasome pathway, metallothionein function, and the extracellular matrix (Table 2 ). The specific genes were chosen because they were in the top 25 when ranked according to fold-change and p-value, have previously been associated with muscle atrophy (2, 3, 8, 23, 24, 32, 42, 48) , and had antibodies to the gene product available commercially.
qRT-PCR
UBE2E, an E2 ubiquitin-conjugating enzyme and FBX09, a ubiquitin-specific ligase (E3), were found to be upregulated 1.6-fold and 1.9-fold using the microarray. However, the more sensitive qRT-PCR technique revealed that mRNA content was only increased 1.2-fold and 1.1-fold, respectively, and this increase was not considered significant (p>0.05, n.s.). We therefore did not perform additional analysis at the protein level for these genes.
In contrast, USP-6, a ubiquitin-specific enzyme that provides a de-ubiquitinating role in the cell, and the small ubiquitin-related modifier (SUMO-1) which functions to prevent proteasome-mediated degradation of proteins (16) , were found to be upregulated 1.8-fold and 1.9-fold, respectively (p<0.05) via qRT-PCR in agreement with the microarray analysis ( Table 2) .
Several genes involved in metallothionein function were upregulated in the microarray dataset. We chose to confirm each of these using qRT-PCR and data showed that there was a 2.6-fold, 2.1-fold, 1.7-fold and 2.0-fold increase in mRNA content for metallothioneins 2A, 1F, 1H, and 1X, respectively (p<0.05), in agreement with the increase observed via microarray analysis (Table 2) .
qRT-PCR analysis of matrix metalloproteinase domain 28 (MMP-28) and tissue inhibitor of metalloproteinase 1 (TIMP-1), enzymes involved in ECM turnover, confirmed the decrease seen with the microarray analysis, revealing a 1.9-fold and 1.8-fold decrease, respectively (p<0.05). Collagen III (COLIII) and collagen IV (COLIV), components of the ECM, were found to be down regulated 2.3-fold and 1.8-fold, respectively (p<0.05).
Western Blotting
To identify if the Akt signaling pathway was affected by the 48h limb immobilization intervention, we performed Western blotting on total Akt, Akt ser473 , Akt thr308 , PTEN ser380 , PDK1 ser241 , GSK3-ser9 , and Raf-1 ser259 . Results of the western blotting indicated that after 48h immobilization, total Akt was unchanged, but there was a significant (p<0.05), 25%
and 10% decrease in phosphorylation of Akt ser473 and Akt thr308, respectively ( Figure 2 ).
Western blotting for components upstream of Akt indicates that phosphorylation of PTEN ser380 showed a trend for an increase of ~9% (p=0.05) and phosphorylation of PDK1 ser241 showed a trend for a decrease of ~22% (p=0.06) in response to 48h of immobilization ( Figure 3 ). Western blotting for downstream components, GSK3-ser9 , and Raf-1 ser25 , showed a trend that phosphorylation of GSK3-ser9 was decreased ~21%
(p=0.05), although phosphorylation of Raf-1 ser25 showed only a modest, non-significant increase (~6%, p=0.34) (Figure 4) .
Western blotting was then performed on protein products of USP-6 and SUMO-1.
Despite significant increases in mRNA content, protein levels for USP-6 and SUMO-1
were unchanged (p>0.05) ( Figure 5 ). Also, we used a monoclonal antibody against metallothionein-1 to assess protein levels of the metallothioneins after 48h of immobilization. Despite the increases observed in mRNA content, protein levels of metallothionein did not change as a result of 48h of immobilization (p>0.05) ( Figure 6 ).
Although mRNA content for matrix metalloproteinase domain 28 (MMP-28) and tissue inhibitor of metalloproteinase 1 (TIMP-1) was increased, Western blotting for protein products of MMP-28 and TIMP-1 showed that protein levels were unchanged as a result of 48h of immobilization (p>0.05) ( Figure 7 ). In contrast, protein levels of structural proteins, COLIII and COLIV, were decreased 88% and 28%, respectively (p<0.05) following 48h of immobilization ( Figure 8 ).
In addition to Western blotting for components of the Akt pathway and each protein of interest, membranes were also incubated in a polyclonal antibody against GAPDH.
Results of the Western blotting analysis revealed that there was no change in protein levels for GAPDH after 48h of immobilization (p>0.8, n.s.). Figure 6 provides a representative blot for GAPDH.
Immunohistochemistry (IHC)
Immunohistochemical analysis was first performed on COLIII and COLIV since these were the only proteins whose levels were found to be altered as a result of the immobilization intervention. Figure 9 (Panels A and B) depicts sections from muscle biopsies taken at baseline and 48h following immobilization using monoclonal antibodies targeted against COLIII, and COLIV. Both instances show decreased staining for these proteins along the extracellular matrix.
To ensure that the protein isolation procedure did not affect our western blotting results (e.g. elimination of protein products not in the supernatant) we performed IHC on SUMO-1, USP-6, and metallothionein. In accordance with western blotting results, we did not document any changes in protein levels, or location of protein products with IHC analysis (data not shown).
DISCUSSION
The overall aim of the present investigation was to use microarray technology to examine Ubiquitin proteasome pathway. In part, the results from this study support our hypothesis that 48h of limb immobilization results in an increase in gene expression for components of the ubiquitin proteasome pathway in humans. Since degradation of proteins via the ubiquitin proteasome pathway is a multi-step process, activation of several components of this pathway is necessary for the accelerated protein breakdown, which occurs in response to catabolic conditions (33, 39) . Increases in mRNA content for various components of the ubiquitin proteasome pathway have been documented in previous muscle atrophy models in animals (7, 8, 14, 19, 22, 24, 32, 37, 48, 51) and humans (24) .
We report here that microarray analysis identified increased expression of an E2
conjugating enzyme (UBE2E), which functions in the proteasome pathway to attach ubiquitin-tagged proteins to E3 ligases (35, 37) . E3 ligases act in the ubiquitin proteasome pathway to alter the structure of the ubiquitin-protein complex so that it can be inserted into the proteolytic core for degradation (35, 37) . The microarray analysis showed that expression of the E3 ligase (FBX09) was also increased following 48h of immobilization. Despite this increase, we were unable to confirm alterations in UBE2E
and FBX09 mRNA content using the more sensitive qRT-PCR technique, suggesting that the microarray technique did not provide a valid assessment of the expression of these genes. Furthermore, these results reinforce the critical need to perform confirmational work using qRT-PCR when performing microarray analysis.
Both the microarray analysis and qRT-PCR documented an increase in expression for USP-6 and SUMO-1, which also function in the ubiquitin proteasome pathway. USP-6 is a de-ubiquitinating enzyme that cleaves ubiquitin from the ubiquitin-tagged proteins so that ubiquitin molecules can be recycled and reused, maintaining increased activity of the pathway during catabolic states (4). This is the first paper to show an increase in mRNA content for USP-6 in human skeletal muscle, as previous work has focused on the role of USP-6 in bone as a tumor suppressor gene (41) . This gene is also increased in response to muscle atrophy suggesting that it serves a growth suppression function, perhaps by maintaining increased ubiquitination and subsequent degradation of proteins. Future work is warranted to explore the expression of this gene at various time points during the course of muscle atrophy, as the significance of this alteration at a single time point, with no concomitant alteration in protein levels, is unclear.
SUMO-1, a small ubiquitin-related modifier, was also increased following 48h of immobilization according to the microarray and qRT-PCR analysis. This finding is unique because previous experiments have shown that SUMO-1 functions to prevent proteasome-mediated degradation of proteins (16) . The ability of SUMO-1 to stabilize proteins that are mis-folded or tagged for degradation, particularly during conditions that precede muscle atrophy, makes it an ideal target for intervention. Thus, we explored protein levels of SUMO-1 at baseline and after 48h of immobilization. Western blot analysis failed to confirm that protein levels of SUMO-1 were altered at this time point.
Immunohistochemical analysis also failed to show any alterations in the location or abundance of SUMO-1 protein as a result of 48h immobilization. This finding does not rule out the possibility that SUMO-1 protein levels are altered as a result of disuse since additional work is necessary to examine the time course of alterations in gene expression and respective protein products.
Although our findings indicate that increased content of mRNA for two components of the ubiquitin proteasome pathway, USP-6 and SUMO-1, occurs in response to 48h of limb immobilization, they do not coincide with previous atrophy models that show an increase in mRNA content for E2 conjugating enzymes and the E3 ligases, Atrogin-1 and MuRF (8, 32, 34, 51) . In contrast to the present study, Bodine et al. (8) included on the Human U133 GeneChip, so we performed targeted analysis of gene expression using custom designed primers (Table 1 ) and the more sensitive qRT-PCR technique. In spite of this approach, mRNA content for Atrogin-1 and MuRF was unchanged after 48h of immobilization ( Table 2 ).
The reason for this discrepancy between data from animal models and from our study regarding Atrogin-1 and MuRF is unclear. A previous study in humans used targeted gene expression analysis (qRT-PCR) towards genes involved in the ubiquitin proteasome pathway at two weeks following limb immobilization (24) ; although that study showed a 62% increase in Atrogin-1 expression (p<0.01), the authors failed to document changes in MuRF and another E3 ligase previously reported to be upregulated in animal models of muscle atrophy. Additionally, a recent study examining the expression of ubiquitin proteasome pathway components in response to age-associated sarcopenia (54) has also failed to identify alterations in Atrogin-1 and MuRF mRNA content. Thus far, work in humans (24, 26, 54) suggests that there is a distinctive pattern of gene expression alterations that regulate the atrophy process compared with animal models. To this end, future work performed to explore the activity of ubiquitin proteasome pathway components at multiple time points during the atrophy process will be valuable in facilitating our understanding of the ubiquitin proteasome pathway and its course of action in humans during the atrophy process.
Metallothioneins. One purpose of this study was to use microarray technology to acquire information about novel genes that may play a role in the initiation of the atrophy program in human skeletal muscle. We were successful in this approach as a group of genes, not previously associated with muscle atrophy in humans, showed increased mRNA content after 48h of immobilization. Marked induction of metallothionein mRNA has been documented in skeletal muscle of animals in various catabolic states (23, 29, 32) and in human skeletal muscle 24h following an intense exercise bout (43). This increase is thought to be beneficial to skeletal muscle, but the exact mechanism by which metallothioneins are induced and how they exert their protective effect is still not clear.
Increased metallothionein content in muscle undergoing atrophy may be necessary to detoxify metal-containing compounds. For example, myoglobin is an iron-containing compound released during muscle protein degradation (23) .
Increased metallothionein content has also been associated with exposure to physiological stress situations (e.g. immobilization, sepsis, aging) that result in elevated levels of glucocorticoids and reactive oxygen species (ROS) (23, 28, 29, 43 ).
Metallothioneins preferentially bind zinc, and it has been proposed that increased metallothionein content is induced via glucocorticoids to assist in the accumulation of intracellular zinc (49) . Since zinc is a cofactor involved in the synthesis of proteins and antioxidants, increased intracellular zinc accumulation may prevent ROS-mediated DNA or cellular damage (28).
Our results show, in a human model, that gene expression for several metallothionein isoforms is increased in response to 48h of immobilization. However, we were unable to document an increase in metallothionein protein levels after 48h of immobilization.
These findings indicate that the atrophy program in humans is marked by an early transcriptional response in metallothionein, possibly as a consequence of elevated levels of heavy metals, ROS or glucocorticoids in response to immobilization. It is possible that protein levels of metallothionein are elevated at later time points in the atrophy program when the rate of protein degradation increases and heavy metals and ROS begin to accumulate in the cell.
Extracellular
Matrix. An unexpected finding in the present investigation was the number of genes involved in the extracellular matrix showing decreased mRNA content following the 48h immobilization intervention (Table 2) . Moreover, western blot and immunohistochemical analysis showed that protein products of genes involved in extracellular matrix structure and integrity, COLIII and COLIV, were decreased.
Our data agree with earlier observations in animal muscle showing a decrease in COLIII and COLIV mRNA in various atrophy conditions (2, 3, 14) . Additionally, previous work in animals has shown that immobilization, hindlimb suspension, and microgravity, lead to a decrease of total muscle collagen synthesis rate, particularly COL I, III and IV (2, 3), and this decrease is evident within one day of the intervention. It is well established that skeletal muscle responds rapidly to altered levels of activity (11, 12), and the number of studies that have shown decreased mRNA content for collagen components support the hypothesis that collagen degradation is an initial step in the muscle atrophy process.
We report here that in addition to decreases in mRNA for COLIII and COLIV, protein levels of COLIII and COLIV were reduced 88% and 28%, respectively within 48h of immobilization. Collagen is the most abundant protein in the extracellular matrix (52) and types III and IV are found in the epi/perimysium and basement membranes, respectively (27) . Our results are in agreement with a recent 14-day hindlimb suspension intervention in rats by Giannelli and colleagues (17) reporting decreased levels of COL I and COLIV protein according to western blot and immunohistochemical analysis. The authors suggest that decreased COLIV alters the permeability of the membrane, possibly resulting in a proteolytic imbalance and subsequent atrophy. Others have suggested that decreased protein levels of collagen, such as the documented decease in COLIII and COLIV after 48h in the present study, indicate that when a limb is immobilized, the muscle begins to undergo remodeling within a relatively short time period possibly to accommodate the reduced mechanical load, as well as the fixed length of the muscle and loss of contractile activity (10, 52). Thus, it is reasonable to hypothesize that reduced protein levels of COLIII and COLIV compromise the integrity of the extracellular matrix.
The extracellular matrix is a dynamic structure which regulates cell behavior through the interaction of extracellular matrix molecules with each other, interaction with growth factors, and through extracellular matrix signal transduction pathways. Therefore, when the integrity of the matrix is compromised, normal muscle function is affected (52) .
Previous work in animals has suggested that decreased collagen within the extracellular matrix increases the activity of intracellular signaling cascades involved in protein breakdown (3, 17) . Extracellular matrix proteins also function to interact with cell surface receptors, including growth factor receptors, to initiate signal transduction pathways responsible for muscle growth and maintenance. Thus, a reduction in COLIII and COLIV protein levels will have a detrimental effect on downstream pathways responsible for protein synthesis and turnover. Additionally, chronic instability of the extracellular matrix due to a loss of collagen content is likely to induce various signaling networks responsible for protein degradation, including the ubiquitin proteasome pathway.
Breakdown of the extracellular matrix components COLIII and COLIV is initiated by matrix metalloproteinases (MMPs) (27) . at both the mRNA and protein levels, with the latter occurring upwards of seven days (17) . Unfortunately, the literature regarding these changes is limited, making it difficult to draw conclusions as to why these alterations occur, and more importantly, how MMPs and TIMPs can be manipulated to attenuate losses to ECM integrity in response to disuse. 
